MPD: List measures where strain SM/J is an outlier

List measures where SM/J is an outlier

Click on pulldowns below to see SM/J means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Ackert1:16	Ackert1	DXA	(none)	bone mineral content (BMC) [g] BMC 25016 6mo 12mo 20mo	inbred	32	both		N=7	2008

Ackert1:21	Ackert1	DXA	(none)	whole body bone area, head excluded [cm²] bone_area 25021 6mo 12mo 20mo	inbred	32	both		N=7	2008

Albers1:2	Albers1	lipid profile	high-fat diet	HDL cholesterol (plasma HDL) [mmol/L] HDLC 1902 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Berndt2:8	Berndt2	plethysmography	methacholine	breath frequency [n/min] breath_freq 35108 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:21	Berndt2	plethysmography	methacholine	expiratory phase [s] expiratory 35121 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:28	Berndt2	plethysmography	methacholine	respiratory cycle [s] tot_respi 35128 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:34	Berndt2	plethysmography	methacholine	duty cycle [ratio] duty_cycle 35134 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:91	Berndt2	ventilator	methacholine	lung tissue dynamic elastance (H₂0 pressure) [cm/mL] airway_elas 35191 saline 1 MCh 3 MCh 10 MCh 30 MCh response index	inbred	29	both	9-12wks	N=9	2010

Brown2:11	Brown2	Barnes circular maze	(none)	acquisition training mean errors [n] acq_err 22511 day1 day4	inbred	13	both	10-18wks	N=12	2004

Bryant1:21	Bryant1	conditioned place preference test	(none)	distance traveled on day 8 (drug free), 30 min test [m] distance_CPP_d8 118057 group: saline oxycodone	inbred	29	both	6-13wks	N=4	2022

Bryant1:45	Bryant1	elevated plus maze	oxycodone	time spent in center zone, 5 min test [s] time_center_EPM 118081 group: saline oxycodone	inbred	29	both	10-17wks	N=4	2022

CGDpheno1:1	CGDpheno1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 31801	inbred w/CC8	72	both	11wks	N=7	2009

Cheverud1:15	Cheverud1	body weight	high-fat diet	growth rate, age 11 to 20 wks [g/wk] gr_adult 17816 control diet high-fat diet	LGXSM w/par	17	both	12-16wks	N=8	2004

Cheverud1:45	Cheverud1	hormone quantification	high-fat diet	insulin (serum) [ng/mL] insulin 17840 control diet high-fat diet	LGXSM w/par	17	both	20-30wks	N=8	2004

Cheverud1:53	Cheverud1	lipid profile	high-fat diet	triglycerides (serum TG, 4h fast) [mg/dL] TG 17844 control diet high-fat diet	LGXSM w/par	17	both	20-30wks	N=8	2004

Cheverud1:59	Cheverud1	body weight	high-fat diet	body weight on high-fat diet [g] bw_hifat 17851 age (wks): 4 5 6 7 9 11 15 19 23	LGXSM w/par	18	both	12-16wks	N=8	2004

Cheverud1:69	Cheverud1	colony observation	(none)	age at necropsy (local parameter) [wks] nec_age 17899	LGXSM w/par	17	both		N=16	2004

Crowley1:29	Crowley1	behavior observation	haloperidol	tongue protrusions, 15 min test [n] tongue 39429 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

CSNA01:71	CSNA01	body weight	sucrose	percentage of starting body weight [%] bw 60271 day 1 before day 1 after day 2 before day 2 after day 3 before day 3 after (2 more)...	HMDP	84	m	7-22wks	N=4	2018

Donahue1:18	Donahue1	hormone quantification	(none)	insulin-like growth factor 1 (adjusted serum IGF-1) [ng/mL] IGF_1 11532	inbred w/CC7	30	both	15-16wks	N=9	2002

Graubert1:16	Graubert1	histopathology	ENU	lung adenoma frequency rate [score] adenoma_lung 11616 control ENU	inbred	20	both	13-68wks	N=6	2006

Hadsell2:9	Hadsell2	mineral quantification	(none)	milk zinc (Zn) concentration [µM] zinc 110067	inbred	31	f	14-20wks	N=8	2018

Harrill2:25	Harrill2	urinalysis	DB289	urine volume [mL] urine_vol 44125 control DB289 difference	inbred	33	f	6-8wks	N=5	2012

Harrill2:31	Harrill2	urinalysis	DB289	creatinine (urine CREA) [mg/mL] urine_CREA 44131 control DB289 difference	inbred	31	f	6-8wks	N=5	2012

Hawes1:18	Hawes1	slit lamp	(none)	punctate or snowflake cataract [frequency rate] cat_punctate 26718	inbred w/CC7	40	both	6-7wks	N=10	2008

Kumar4:9	Kumar4	gait analysis	(none)	lateral displacement of base of tail keypoint, median base_tail_lateral_displacement_median 114439	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:10	Kumar4	gait analysis	(none)	lateral displacement of base of tail keypoint, variance base_tail_lateral_displacement_var 114440	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:13	Kumar4	gait analysis	(none)	limb duty factor, hind paws (keypoints), variance limb_duty_factor_var 114443	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:16	Kumar4	gait analysis	(none)	lateral displacement of nose keypoint, variance nose_lateral_displacement_var 114446	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:22	Kumar4	gait analysis	(none)	distance right hind paw keypoint travels past previous left hind paw keypoint strike, variance [cm] step_length1_var 114452	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:24	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels past the right hind paw keypoint strike, median [cm] step_length2_median 114454	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:25	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels past the right hind paw keypoint strike, variance [cm] step_length2_var 114455	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:31	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels for a stride, from toe-off to foot-strike, variance [cm] stride_length_var 114461	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:37	Kumar4	gait analysis	(none)	lateral displacement of tip of tail keypoint, variance tip_tail_lateral_displacement_variance 114467	inbred w/CC8	62	both	10-20wks	N=19	2021

Maurer1:25	Maurer1	ECG	atenolol, isoproterenol	amplitude of S-wave [mV] S_amp 33225 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=9	2009

Maurer1:57	Maurer1	ECG	atenolol, isoproterenol	area of QRS [ms*mV] QRSarea 33257 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=9	2009

Mills1:25	Mills1	chromosome instability assessment	(none)	reticulocytes with micronuclei [%] retic_micronucl 25225 6mo 12mo 20mo	inbred	30	both		N=5	2008

Mogil1:27	Mogil1	nociception assay	(none)	percent hypersensitivity threshold to bee venom-induced thermal hyperalgesia (contralateral), untreated and heated hindpaw withdrawal [%] BV_HT_CON 2227	inbred	12	m	6-18wks	N=5	2002

Mooney2:11	Mooney2	fear conditioning test	nicotine	percent freezing during a 3 min PreCS exposure in a novel context [%] precs 110088 mg/kg/day: 0 12 18	inbred	21	m	8-12wks	N=10	2019

Paigen1:36	Paigen1	histopathology	high-fat diet	fatty streak aortic lesion size [µm²] aortic_lesion 2936	inbred	44	both	15-19wks	N=8	2000

Paigen2:24	Paigen2	histopathology	high-fat diet	fatty streak aortic lesion size [µm²] aortic_lesion 9924	inbred w/CC7	42	both	25-27wks	N=9	2002

Peters4:73	Peters4	complete blood count	(none)	mean RBC corpuscular volume (MCV) [fL] MCV 24373 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:85	Peters4	complete blood count	(none)	reticulocyte corpuscular hemoglobin (CHr) [pg] CHr 24385 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Project1032:53	Project1032	operant conditioning chamber	(none)	number of active lever presses (during infusions and timeouts) (intravenous self administration), saline [n] active_control 111466 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:73	Project1032	operant conditioning chamber	(none)	number of active lever presses (during infusions and timeouts) (intravenous self administration) combined, saline [n] active_combined_control 111486 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=2	2020

Project1149:45	Project1149	None	(none)	time_center_EPM time_center_EPM 118142 SAL OXY	inbred	29	m		N=8	2022

Reed1:9	Reed1	organ weights	(none)	kidney weight [g] kidneys 32609 weight [g] as percent of body weight [%]	inbred	28	m	29-67wks	N=12	2009

Rhodes1:11	Rhodes1	body weight	exercise	change in body weight [ratio] BW_chg 34611 control with running wheel	inbred	12	both	15wks	N=4	2010

Tarantino1:8	Tarantino1	open field test	cocaine	rearing episodes, 30 min test [n] rear 45921 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tordoff1:9	Tordoff1	bottle choice test	(none)	preference for KCl (potassium chloride) solutions [%] KCl_pref 6109 concentration (mM): 10 30 100 200 300	inbred	28	m	4-12wks	N=12	2001

Tordoff1:22	Tordoff1	bottle choice test	(none)	preference for NH4Cl (ammonium chloride) solutions [%] NH4Cl_pref 6122 concentration (mM): 10 30 100 300	inbred	28	m	4-12wks	N=11	2001

Wahlsten1:4	Wahlsten1	organ weights	(none)	brain weight, after fixation and trimming [g] brain_wt 10804 weight as percent of body weight	inbred	21	both	12wks	N=10	2003

Wahlsten1:11	Wahlsten1	histopathology	(none)	cross-sectional area of anterior commissure at midplane [mm²] ac_area 10811	inbred	21	both	12wks	N=10	2003

Wahlsten1:14	Wahlsten1	histopathology	(none)	anterior commissure index (0=absent, 1=normal, <.60 is abnormal) [score] ac_index 10814	inbred	21	both	12wks	N=10	2003

Wahlsten1:54	Wahlsten1	elevated plus maze	(none)	time spent in center 5 x 5 cm hub [s] center 10854	inbred	21	both	9wks	N=9	2003

Wiltshire2:1	Wiltshire2	tail suspension test	fluoxetine	TST duration of immobility [%] TST 38001 control fluoxetine	inbred	30	m	9-10wks	N=10	2011

Wiltshire4:1	Wiltshire4	immune cell quantification	BEZ235	B cells, percent viability [%] Bcells_BEZ 52401 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:47	Wiltshire4	immune cell quantification	idarubicin	T cells, percent viability [%] Tcells_Ida 52447 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Yuan1:1	Yuan1	hormone quantification	(none)	insulin-like growth factor 1 (serum IGF-1) [ng/mL] IGF1 27001 6mo 12mo 18mo	inbred	33	both		N=7	2007

Yuan3:51	Yuan3	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 24451 6mo 12mo 18mo	inbred	32	both		N=6	2008

Zimmermann1:9	Zimmermann1	monitoring system	(none)	fine or stationary movement on x-y axis, repeated interruptions of same beam, second day (beam breaks/min) [n/min] fine_act 112172 during light during dark	inbred	30	both	7-15wks	N=11	2020

List measures where SM/J is an outlier

Filter Table Results